Marinova is an Australian biotechnology company dedicated to the development and production of high purity seaweed extracts for the betterment of human health. The company specialises in the manufacture of fucoidan compounds – highly bioactive polysaccharides derived from select species of brown seaweed.
As the global leader in fucoidan science, Marinova is the supplier of choice to world renowned research institutions and some of the most recognised companies in the nutraceutical and pharmaceutical sectors. Marinova's product portfolio includes certified organic fucoidan extracts for nutritional and topical applications through to highly characterised fractions for medical devices and pharmaceutical development.
Marinova's reputation is built on the unrivalled quality and efficacy of its products. It is further underpinned by an extensive research and development program that has launched fucoidan into the new frontier of natural therapeutics.